Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06043440 · ClinicalTrials.gov registry record · Phase 2
Down Syndrome Obstructive Sleep Apnea
A Phase 2 study of Obstructive Sleep Apnea and Down Syndrome, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 230
- Enrollment target
- 7
- Study locations
NCT06043440 is a Phase 2 study of Obstructive Sleep Apnea and Down Syndrome that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 230 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 7 study locations across 6 states.
The verdict
NCT06043440, a Phase 2 study of Obstructive Sleep Apnea and Down Syndrome, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 230 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) with moderate to severe Obstructive Sleep Apnea (OSA).
Conditions Studied
Interventions
- DRUG Oxygen
Study Locations (7)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Rainbow Babies and Children's Hospital, Case Medical Center - Cleveland
California
- Children's Hospital of Los Angeles - Los Angeles
Michigan
- University of Michigan, Ann Arbor Hospital - Ann Arbor
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Virginia
- East Virginia Medical Center - Norfolk
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2023-10-24 |
| Est. Completion | 2027-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06043440
The ClinicalTrials.gov registry entry for NCT06043440 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Oxygen is the first listed.
NCT06043440 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Ohio, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT06043440 about?
NCT06043440 is a clinical study titled "Down Syndrome Obstructive Sleep Apnea". The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) with moderate to severe Obstructive Sleep Apnea (OSA).
What is the current status of trial NCT06043440?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 230 participants. The study started on 2023-10-24. Estimated completion is 2027-12-30.
What conditions does trial NCT06043440 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Down Syndrome.
What interventions are being tested in trial NCT06043440?
The interventions under investigation include: Oxygen (DRUG).
Who is sponsoring clinical trial NCT06043440?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06043440 being conducted?
This trial has 7 study locations across California, Michigan, Ohio, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
RECRUITING · Phase 2
-
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Endotypic Traits and Obstructive Sleep Apnea Surgery
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.